Faculty Opinions recommendation of Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

2013 ◽  
Author(s):  
Christof Westenfelder ◽  
Florian Toegel
Keyword(s):  
Heart Failure ◽  
Decompensated Heart Failure ◽  
Cardiorenal Syndrome

scholarly journals The Role of Ultrafiltration in Patients with Decompensated Heart Failure

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Sandeep A. Kamath
Keyword(s):  
Heart Failure ◽  
Decompensated Heart Failure ◽  
Cardiorenal Syndrome ◽  
Loop Diuretics ◽  
Inpatient Setting ◽  
Effective Volume ◽  
Primary Driver ◽  
High Doses

Congestion, due in large part to hypervolemia, is the primary driver of heart failure (HF) admissions. Relief of congestion has been traditionally achieved through the use of loop diuretics, but there is increasing concern that these agents, particularly at high doses, may be deleterious in the inpatient setting. In addition, patients with HF and the cardiorenal syndrome (CRS) have diminished response to loop diuretics, making these agents less effective at relieving congestion. Ultrafiltration, a mechanical volume removal strategy, has demonstrated promise in achieving safe and effective volume removal in patients with cardiorenal syndrome and diuretic refractoriness. This paper outlines the rationale for ultrafiltration in CRS and the available evidence regarding its use in patients with HF. At present, the utility of ultrafiltration is restricted to selected populations, but a greater understanding of how this technology impacts HF and CRS may expand its use.

Worsening renal function in children hospitalized with decompensated heart failure: Evidence for a pediatric cardiorenal syndrome?*

2008 ◽  
Vol 9 (3) ◽  
pp. 279-284 ◽  
Author(s):  
Jack F. Price ◽  
Antonio R. Mott ◽  
Heather A. Dickerson ◽  
John Lynn Jefferies ◽  
David P. Nelson ◽  
...  
Keyword(s):  
Heart Failure ◽  
Renal Function ◽  
Decompensated Heart Failure ◽  
Cardiorenal Syndrome ◽  
Worsening Renal Function

scholarly journals Cardiorenal syndrome in decompensated heart failure

Heart ◽  
2009 ◽  
Vol 96 (4) ◽  
pp. 255-260 ◽  
Author(s):  
W. H. W. Tang ◽  
W. Mullens
Keyword(s):  
Heart Failure ◽  
Decompensated Heart Failure ◽  
Cardiorenal Syndrome

PT102 Acute Cardiorenal Syndrome in Decompensated Heart Failure: Impact on Outcomes After Hospital Discharge

Global Heart ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e143
Author(s):  
P.P.D.M.S. Spineti ◽  
E.F. Salles ◽  
P.D.F.M. Ferreira ◽  
L.L. Perruso ◽  
P.D. Maia ◽  
...  
Keyword(s):  
Heart Failure ◽  
Hospital Discharge ◽  
Decompensated Heart Failure ◽  
Cardiorenal Syndrome

Ultrafiltrazione peritoneale e sindrome cardiorenale: gestione del sovraccarico di fluidi e ruolo del sodio

2019 ◽  
Vol 31 (2) ◽  
pp. 100-105
Author(s):  
Luca Di Lullo ◽  
Claudio Ronco ◽  
Fulvio Floccari ◽  
Antonio De Pascalis ◽  
Rodolfo Rivera ◽  
...  
Keyword(s):  
Heart Failure ◽  
Peritoneal Dialysis ◽  
Diuretic Therapy ◽  
Decompensated Heart Failure ◽  
Cardiorenal Syndrome ◽  
Therapeutic Modality ◽  
Heart Failure Patients ◽  
Sodium Removal ◽  
Refractory Heart Failure ◽  
Home Based

Congestion represents a crucial clinical component of both heart failure and cardiorenal syndrome and it has been postulated to modulate heart and kidney cross-link. Diuretic therapy is a corner stone in the treatment patients with heart failure, and renal replacement therapies are mainly used for patients with refractory heart failure who have not reached the worst stages of renal disfunction. Peritoneal dialysis is a home-based therapeutic modality providing both solute clearance and ultrafiltration, together with relief from congestion in decompensated heart failure patients. The following review will focus on sodium removal in refractory decompensated heart failure patients undergoing peritoneal dialysis. (Cardionephrology)

Sign in / Sign up

Export Citation Format

Share Document